Phycin
Next-Generation Stable Growth Factors
- Business Model
- B2B
- Website
- phycin.com
- Total Funding
- $200K
- Last Round
- $200K Pre-SeedJul 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Phycin develops more stable, AI-engineered growth factors for regenerative medicine, cell culture, and life science research applications.
Summary
Phycin is a Biotech company. It has raised $200K in total across 2 rounds, most recently a $200K Pre-Seed round in Jul 2024. Investors include TEDCO.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2024
Sign up to see all 2 events
Funding: Grant through Pre-Seed. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/phycin"><img src="https://indexed.vc/api/badge/company/phycin" alt="Phycin on Indexed.vc" width="260" height="76" /></a>